214 related articles for article (PubMed ID: 2481785)
1. Clinical and hemodynamic effects of celiprolol in essential hypertension.
Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
[TBL] [Abstract][Full Text] [Related]
2. Celiprolol--overview of 6 years of clinical trials experience.
Pruss TP; Lamon KD; Hagen NS
J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
[TBL] [Abstract][Full Text] [Related]
3. 24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.
Parati G; Pomidossi G; Casadei R; Ravogli A; Trazzi S; Mutti E; Mancia G
J Int Med Res; 1988; 16 Suppl 1():52A-61A. PubMed ID: 2975612
[TBL] [Abstract][Full Text] [Related]
4. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
5. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antihypertensive effects of celiprolol and enalapril.
Ghiringhelli S; Cozzi E; Tsialtas D
J Int Med Res; 1988; 16 Suppl 1():73A-79A. PubMed ID: 2906019
[TBL] [Abstract][Full Text] [Related]
7. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
Matthys H; Doshan HD; Rühle KH; Applin WJ; Braig H; Pohl M
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S40-2. PubMed ID: 2427851
[TBL] [Abstract][Full Text] [Related]
8. Celiprolol and atenolol in angina--effects on left ventricular function.
Dargie H; McLenachan JM; Wilson JT
J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
[TBL] [Abstract][Full Text] [Related]
9. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
Doshan HD; Rosenthal RR; Brown R; Slutsky A; Applin WJ; Caruso FS
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S105-8. PubMed ID: 2427836
[TBL] [Abstract][Full Text] [Related]
10. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
Weigmann I; Terhaag B; Wierich W; Herrmann WM
Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
[TBL] [Abstract][Full Text] [Related]
12. [Effect of celiprolol compared to propranolol on thyroid metabolism].
Langsteger W; Lind P; Eber O
Wien Med Wochenschr; 1985 Sep; 135(18):451-7. PubMed ID: 2865857
[TBL] [Abstract][Full Text] [Related]
13. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
[TBL] [Abstract][Full Text] [Related]
14. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
Milne RJ; Buckley MM
Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
Soberman JE; Frishman WH
J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S9-13. PubMed ID: 2481791
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
Norris RJ
Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
18. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
19. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
Riddell JG; Shanks RG; Brogden RN
Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
[TBL] [Abstract][Full Text] [Related]
20. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
